key: cord-0941209-752oitn3
authors: Kataoka, Michiyo; Tsukamoto, Tetsuya; Tajima, Yasuhisa; Sato, Yuko; Katano, Harutaka; Suzuki, Tadaki; Nakajima, Noriko
title: Coronavirus hunted in human pneumocytes and alveolar macrophages: a case report
date: 2022-03-31
journal: Histopathology
DOI: 10.1111/his.14637
sha: 3743de9904850afe5b0e9e8388de8fec887e7e62
doc_id: 941209
cord_uid: 752oitn3

nan

. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles in type II pneumocytes. A, Double staining with antibodies against SARS-CoV-2 nucleoprotein (NP) antigens and epithelial membrane antigen (EMA). SARS-CoV-2 NP antigens (brown) are positive in the EMA-positive pneumocytes (green). Scale bar: 10 lm. B, Numerous virus particles are visible in the large vesicles within the cytoplasm of type II pneumocytes. Scale bar: 1 lm. C, Higher magnification of the red boxed area in (B). Scale bar: 100 nm. D, Tubular structures are observed together with viral particles in vesicles within the cytoplasm of type II pneumocytes. Scale bar: 100 nm. E, Immunogold labelling of SARS-CoV-2 particles with a rabbit antibody against SARS-CoV-2 NP antigens and a donkey anti-rabbit immunoglobulin conjugated to 6-nm gold particles. Scale bar: 100 nm. F, A region of double-membrane vesicles, which constitute a common feature of coronavirus-infected cells. Scale bar: 1 lm. G, Higher magnification of the red boxed area in (F) showing the presence of thin and electron-dense filaments in the double-membrane vesicles. Scale bar: 500 nm. LB, lamellar body. lung tissue, and clarified the differences between the two cell types.

A 64-year-old woman (body mass index of 31) with COVID-19 was admitted to the hospital with severe general fatigue. During admission, she had no fever or respiratory symptoms, but her creatinine kinase and troponin I levels were high. After 9 h, she developed chest pain and ventricular fibrillation, and she died within 72 h. We suspected fulminant myocarditis. Autopsy indicated mild myocarditis and marked pulmonary congestion with rare hyaline membrane formation. SARS-CoV-2 RNA was detected at low titres in the heart and at high levels (>10 7 copies/lg RNA) in the lungs. Enzyme-antibody double immunostaining revealed SARS-CoV-2 nucleoprotein (NP) antigens in epithelial membrane antigen-positive type II pneumocytes and CD68-positive alveolar macrophages ( Figures 1A and 2A) .

In type II pneumocytes, TEM analysis revealed many coronavirus particles within a large cytoplasmic vesicle (diameter of 1.73 lm) ( Figure 1B ). The diameter of the viral particles averaged 78.2 nm, Figure 1C ). Within the viral particles, small electron-dense spots (average diameter of 8.6 nm), reflecting cross-sections through the helical nucleocapsids, were clearly observed ( Figure 1C ). Smaller cytoplasmic vesicles (average diameter of 258 nm), containing approximately 5-20 virus particles ( Figure 1D ), were observed more frequently than larger vesicles ( Figure 1B) . The viral particles were confirmed by the use of immunogold electron microscopy (EM) with an antibody against SARS-CoV-2 NP antigens ( Figure 1E) . No viral particles were found outside the vesicles, as previously reported. 3 It is noted that tubular structures (average diameter of 30 nm) were observed together with virus particles in the smaller vesicles ( Figure 1D ). Goldsmith et al. 4 reported similar tubular structures in the vesicles of SARS-CoV-infected cultured cells. Here, for the first time, we confirmed the presence of the same structure in SARS-CoV-2-infected human lung tissue. In addition, double-membrane vesicles (DMVs), which are formed during coronavirus replication and derived from the endoplasmic reticulum of the host cell, were observed in type II pneumocytes (Figure 1F,G) . The average diameter of the DMVs was 324 nm, which is consistent with that observed in SARS-CoV-2-infected VeroE6 cells. 5 Thin and electron-dense filaments, presumably representing viral RNA, were clearly observed in the DMVs ( Figure 1G ).

It is still unclear whether the alveolar macrophages test positively for viral antigens and/or viral RNA because they phagocytose viral particles or because they are infected with SARS-CoV-2. In studies of invitro infection, human monocyte-derived macrophages can be infected with SARS-CoV-2, but they fail to support the production of progeny virus. 6 In double immunostaining of alveolar macrophages, viral antigens were often detected localized to a small portion of the cytoplasm (Figure 2A, left panel) , and, rarely, some were detected diffusely (Figure 2A , right panel). Corresponding with this observation, TEM revealed alveolar macrophages phagocytosing type II pneumocytes ( Figure 2B,C) . The phagocytosed type II alveoli had vesicles containing numerous viral particles and tubular structures ( Figure 2B,C, left panel) , whereas, in the cytoplasm of the macrophage, a vesicle with a few viral particles and tubular structures was observed ( Figure 2C, right panel) . The particles in the vesicles ( Figure 2D ) were identified as SARS-CoV-2 by the use of immunogold EM ( Figure 2E ). Some macrophages showed large vesicles with sparse SARS-CoV-2 particles, some of which were irregularly shaped ( Figure 2F ,G). DMVs were not found in the alveolar macrophages.

A limitation of this study was that the findings were based on a single case. Nonetheless, differences in the presence of virus particles in type II pneumocytes and in alveolar macrophages were directly shown by TEM. Alveolar macrophages showed phagocytosis of infected cells, but did not show evidence of active viral replication, such as DMVs, and the amount of viral particles in macrophages was much lower than that in pneumocytes. The tubular structures, which were found in this case and have been reported in cultured cells, are suspected to be related to coronavirus infection, but require further case series and detailed studies.

The authors declare no conflicts of interest. The study sponsor(s) had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the report for publication.

The study complied with the ethical standards of the Ethical Review Committee for Medical Research Involving Human Subjects, National Institute of Infectious Diseases (approval No. 1178, 3 September 2020).Written informed consent was obtained from the patient's family for the publication of the data and accompanying images. 

Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States

Hunting coronavirus by transmission electron microscopy-A guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues

Difficulties in differentiating coronaviruses from subcellular structures in human tissues by electron microscopy

Ultrastructural characterization of SARS coronavirus

SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography

Severe acute respiratory syndrome coronavirus 2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells

We thank Dr Miyamoto for technical advice on immunogold EM. This study was supported in part by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan with a grant to N. Nakajima under grant number 20 K07400, and by